SAN DIEGO, June 15, 2021 /PRNewswire/ -- Prometheus Laboratories, Inc. ("Prometheus"), a leader in precision healthcare, announces the execution of an agreement with MultiPlan, a trusted partner to ...
SAN DIEGO, CA / ACCESSWIRE / May 9, 2024 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision medicine for immune-mediated diseases, announced the execution of provider agreements with ...
When dosing is optimized, biologics such as IFX are highly effective for managing CD and UC. Anser IFX testing uses a drug-tolerant homogeneous mobility shift assay (HMSA) to provide clinicians ...
This latest accomplishment joins the company’s previously secured ASTM certifications, enhancing the features and expanding the end-uses for its microalgae-based bio-cement and bio-concrete. BOULDER, ...
SAN DIEGO, CA / ACCESSWIRE / August 1, 2023 / Prometheus Laboratories Inc. ("Prometheus") today announced a collaboration with Fresenius Kabi to support the validation of and access to Anser ® ...
SAN DIEGO, CA / ACCESS Newswire / August 27, 2025 / Prometheus Laboratories Inc. ("Prometheus"), a leader in precision healthcare, today announced a collaboration with Celltrion USA, Inc. ("Celltrion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback